View in EDS

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Saved in:
Bibliographic Details
Title: Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.
Authors: Roller L; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America., Zhou N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Atre I; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America., Xiong N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Li J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Cheng SC; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America., Liu N; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Lacad D; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Adjei M; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Matulonis UA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Konstantinopoulos PA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Liu JF; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Tayob N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America., Stover EH; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America. Electronic address: elizabeth_stover@dfci.harvard.edu., Shinagare AB; Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States of America.
Source: Gynecologic oncology [Gynecol Oncol] 2026 Jul 02; Vol. 211, pp. 98-107. Date of Electronic Publication: 2026 Jul 02.
Publication Type: Journal Article
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1095-6859
DOI:10.1016/j.ygyno.2026.06.007